Table 1: Patient Demographics and Medication History.

Patient

Age/Gender

Disease

Name of Medication

Route

Duration

1

71 F

Osteoporosis

Fosamax®

Oral

10 years

2

78 M

Prostate cancer with bone metastasis

Zometa®

IV

3 years

3

67 M

Prostate cancer with bone metastasis

Zometa®

IV

4 years